Screener
Alto Neuroscience ANRO Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 2,234 | 1,872 |
| Operating right-of-use asset | 4,061 | 4,261 |
| Other assets | 338 | 338 |
| Total assets | $276,259 | $184,689 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $3,369 | $1,878 |
| Accrued expenses and other current liabilities | 7,610 | 8,862 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Alto Neuroscience's total assets?
- Alto Neuroscience (ANRO) reported total assets of $276.26M in Q1 2026.
- How has Alto Neuroscience's total assets changed year-over-year?
- Alto Neuroscience's total assets increased by 60.7% year-over-year, from $171.92M to $276.26M.
- What is the long-term trend for Alto Neuroscience's total assets?
- Over 2 years (2023 to 2025), Alto Neuroscience's total assets has grown at a 46.0% compound annual growth rate (CAGR), from $86.63M to $184.69M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Alto Neuroscience's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude